April 12: COA Slams MedPAC’s Drug Cost Containment Plan
A set of draft recommendations for controlling price escalation in the Medicare Part B program has ignited fresh concern from the oncology community, which battled last year to overcome the Medicare Part B Drug Payment Model cost reduction experiment. Part B covers injectable and infusion drugs.
April 12: COA Slams MedPAC’s Drug Cost Containment Plan
A set of draft recommendations for controlling price escalation in the Medicare Part B program has ignited fresh concern from the oncology community, which battled last year to overcome the Medicare Part B Drug Payment Model cost reduction experiment. Part B covers injectable and infusion drugs.
